Population pharmacokinetics of theophylline. II: Intravenous infusion to patients with stable chronic airway obstruction

I. Yano, Yusuke Tanigawara, M. Yasuhara, K. Okumura, K. Kawakatsu, K. Nishimura, R. Hori

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The population pharmacokinetics of theophylline were studied in 55 patients with stable chronic airway obstruction. Two hundred and seventy six theophylline serum concentrations after intravenous short infusion were analyzed using a nonlinear mixed-effect model. The influence of hepatic dysfunction, smoking habit, age and the measurement of arterial blood gases (oxygen tension: PaO2, carbon dioxide tension: PaCO2, blood pH) and clinical laboratory tests (serum albumin concentration, haematocrit) on the pharmacokinetic parameters of theophylline was examined by the likelihood ratio test. Assessment of each factor was made by a forward selection method. In the final regression model, the total body clearance (CL, l/h/kg) was related to the value of PaCO2 as well as to the presence of hepatic dysfunction, and the volume of distribution (V(d), l/kg) was related with the PaCO2 value as expressed in the following equations: CL=exp(- 3.78 - 0.525. HF+ 0.0233. PaCO2) and V(d)=exp(- l.12 + 0.00934. PaCO2), where HF is a categorical variable with a value of unity if a patient has hepatic dysfunction otherwise zero. The interactions among blood gas measurements were observed and the CL and V(d) of theophylline would be inversely correlated with PaO2 or pH, if we selected PaO2 or blood pH to be a more important factor than PaCO2. The inter-individual variabilities in CL and V(d) were 38.5% and 12.5%, respectively, and the residual variability in theophylline serum concentrations was 10.6% as a coefficient of variation. This final model and the population parameters of theophylline will be useful for individualization of a drug dosage regimen by means of the Bayesian method. Significant correlation between arterial blood gas measurements and pharmacokinetic parameters observed in this study indicates that the pharmacokinetics of theophylline can vary in association with the severity of respiratory diseases.

Original languageEnglish
Pages (from-to)501-505
Number of pages5
JournalBiological and Pharmaceutical Bulletin
Volume16
Issue number5
Publication statusPublished - 1993
Externally publishedYes

Fingerprint

Airway Obstruction
Theophylline
Intravenous Infusions
Pharmacokinetics
Population
Gases
Liver
Bayes Theorem
Serum
Hematocrit
Carbon Dioxide
Serum Albumin
Habits
Smoking
Oxygen
Pharmaceutical Preparations

Keywords

  • airway obstruction
  • NONMEM
  • population pharmacokinetics
  • theophylline

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Population pharmacokinetics of theophylline. II : Intravenous infusion to patients with stable chronic airway obstruction. / Yano, I.; Tanigawara, Yusuke; Yasuhara, M.; Okumura, K.; Kawakatsu, K.; Nishimura, K.; Hori, R.

In: Biological and Pharmaceutical Bulletin, Vol. 16, No. 5, 1993, p. 501-505.

Research output: Contribution to journalArticle

Yano, I. ; Tanigawara, Yusuke ; Yasuhara, M. ; Okumura, K. ; Kawakatsu, K. ; Nishimura, K. ; Hori, R. / Population pharmacokinetics of theophylline. II : Intravenous infusion to patients with stable chronic airway obstruction. In: Biological and Pharmaceutical Bulletin. 1993 ; Vol. 16, No. 5. pp. 501-505.
@article{ff1915ff19e6408c990f5d84670d157e,
title = "Population pharmacokinetics of theophylline. II: Intravenous infusion to patients with stable chronic airway obstruction",
abstract = "The population pharmacokinetics of theophylline were studied in 55 patients with stable chronic airway obstruction. Two hundred and seventy six theophylline serum concentrations after intravenous short infusion were analyzed using a nonlinear mixed-effect model. The influence of hepatic dysfunction, smoking habit, age and the measurement of arterial blood gases (oxygen tension: PaO2, carbon dioxide tension: PaCO2, blood pH) and clinical laboratory tests (serum albumin concentration, haematocrit) on the pharmacokinetic parameters of theophylline was examined by the likelihood ratio test. Assessment of each factor was made by a forward selection method. In the final regression model, the total body clearance (CL, l/h/kg) was related to the value of PaCO2 as well as to the presence of hepatic dysfunction, and the volume of distribution (V(d), l/kg) was related with the PaCO2 value as expressed in the following equations: CL=exp(- 3.78 - 0.525. HF+ 0.0233. PaCO2) and V(d)=exp(- l.12 + 0.00934. PaCO2), where HF is a categorical variable with a value of unity if a patient has hepatic dysfunction otherwise zero. The interactions among blood gas measurements were observed and the CL and V(d) of theophylline would be inversely correlated with PaO2 or pH, if we selected PaO2 or blood pH to be a more important factor than PaCO2. The inter-individual variabilities in CL and V(d) were 38.5{\%} and 12.5{\%}, respectively, and the residual variability in theophylline serum concentrations was 10.6{\%} as a coefficient of variation. This final model and the population parameters of theophylline will be useful for individualization of a drug dosage regimen by means of the Bayesian method. Significant correlation between arterial blood gas measurements and pharmacokinetic parameters observed in this study indicates that the pharmacokinetics of theophylline can vary in association with the severity of respiratory diseases.",
keywords = "airway obstruction, NONMEM, population pharmacokinetics, theophylline",
author = "I. Yano and Yusuke Tanigawara and M. Yasuhara and K. Okumura and K. Kawakatsu and K. Nishimura and R. Hori",
year = "1993",
language = "English",
volume = "16",
pages = "501--505",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "5",

}

TY - JOUR

T1 - Population pharmacokinetics of theophylline. II

T2 - Intravenous infusion to patients with stable chronic airway obstruction

AU - Yano, I.

AU - Tanigawara, Yusuke

AU - Yasuhara, M.

AU - Okumura, K.

AU - Kawakatsu, K.

AU - Nishimura, K.

AU - Hori, R.

PY - 1993

Y1 - 1993

N2 - The population pharmacokinetics of theophylline were studied in 55 patients with stable chronic airway obstruction. Two hundred and seventy six theophylline serum concentrations after intravenous short infusion were analyzed using a nonlinear mixed-effect model. The influence of hepatic dysfunction, smoking habit, age and the measurement of arterial blood gases (oxygen tension: PaO2, carbon dioxide tension: PaCO2, blood pH) and clinical laboratory tests (serum albumin concentration, haematocrit) on the pharmacokinetic parameters of theophylline was examined by the likelihood ratio test. Assessment of each factor was made by a forward selection method. In the final regression model, the total body clearance (CL, l/h/kg) was related to the value of PaCO2 as well as to the presence of hepatic dysfunction, and the volume of distribution (V(d), l/kg) was related with the PaCO2 value as expressed in the following equations: CL=exp(- 3.78 - 0.525. HF+ 0.0233. PaCO2) and V(d)=exp(- l.12 + 0.00934. PaCO2), where HF is a categorical variable with a value of unity if a patient has hepatic dysfunction otherwise zero. The interactions among blood gas measurements were observed and the CL and V(d) of theophylline would be inversely correlated with PaO2 or pH, if we selected PaO2 or blood pH to be a more important factor than PaCO2. The inter-individual variabilities in CL and V(d) were 38.5% and 12.5%, respectively, and the residual variability in theophylline serum concentrations was 10.6% as a coefficient of variation. This final model and the population parameters of theophylline will be useful for individualization of a drug dosage regimen by means of the Bayesian method. Significant correlation between arterial blood gas measurements and pharmacokinetic parameters observed in this study indicates that the pharmacokinetics of theophylline can vary in association with the severity of respiratory diseases.

AB - The population pharmacokinetics of theophylline were studied in 55 patients with stable chronic airway obstruction. Two hundred and seventy six theophylline serum concentrations after intravenous short infusion were analyzed using a nonlinear mixed-effect model. The influence of hepatic dysfunction, smoking habit, age and the measurement of arterial blood gases (oxygen tension: PaO2, carbon dioxide tension: PaCO2, blood pH) and clinical laboratory tests (serum albumin concentration, haematocrit) on the pharmacokinetic parameters of theophylline was examined by the likelihood ratio test. Assessment of each factor was made by a forward selection method. In the final regression model, the total body clearance (CL, l/h/kg) was related to the value of PaCO2 as well as to the presence of hepatic dysfunction, and the volume of distribution (V(d), l/kg) was related with the PaCO2 value as expressed in the following equations: CL=exp(- 3.78 - 0.525. HF+ 0.0233. PaCO2) and V(d)=exp(- l.12 + 0.00934. PaCO2), where HF is a categorical variable with a value of unity if a patient has hepatic dysfunction otherwise zero. The interactions among blood gas measurements were observed and the CL and V(d) of theophylline would be inversely correlated with PaO2 or pH, if we selected PaO2 or blood pH to be a more important factor than PaCO2. The inter-individual variabilities in CL and V(d) were 38.5% and 12.5%, respectively, and the residual variability in theophylline serum concentrations was 10.6% as a coefficient of variation. This final model and the population parameters of theophylline will be useful for individualization of a drug dosage regimen by means of the Bayesian method. Significant correlation between arterial blood gas measurements and pharmacokinetic parameters observed in this study indicates that the pharmacokinetics of theophylline can vary in association with the severity of respiratory diseases.

KW - airway obstruction

KW - NONMEM

KW - population pharmacokinetics

KW - theophylline

UR - http://www.scopus.com/inward/record.url?scp=0027171814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027171814&partnerID=8YFLogxK

M3 - Article

C2 - 8364499

AN - SCOPUS:0027171814

VL - 16

SP - 501

EP - 505

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 5

ER -